BGI Genomics Co., Ltd. (SHE:300676)

China flag China · Delayed Price · Currency is CNY
48.75
-0.83 (-1.67%)
Sep 26, 2025, 3:04 PM CST
34.74%
Market Cap 18.71B
Revenue (ttm) 3.63B
Net Income (ttm) -915.11M
Shares Out 383.85M
EPS (ttm) -2.23
PE Ratio n/a
Forward PE 744.63
Dividend 0.10 (0.21%)
Ex-Dividend Date Jul 4, 2024
Volume 5,917,807
Average Volume 10,013,496
Open 51.20
Previous Close 49.58
Day's Range 48.70 - 51.20
52-Week Range 35.93 - 70.30
Beta 0.74
RSI 38.84
Earnings Date Oct 31, 2025

About BGI Genomics

BGI Genomics Co., Ltd. provides genomic sequencing and proteomic services in China and internationally. The company offers solutions to various applications, such as basic research covering human, plant, animal, and microbial species; clinical research in human health; genetic testing and screening; drug discovery and development; and agriculture and biodiversity preservation and sustainability. It provides DNA, RNA, and customized sequencing solutions; and mass spec services, as well as COVID-19 PCR test kits and COVID lab solutions. In additi... [Read more]

Sector Healthcare
Founded 1999
Employees 3,702
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300676
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.